Bionic ETF
VanEck Bionic Engineering UCITS ETF
Bionic ETF
VanEck Bionic Engineering UCITS ETF
Fund Description
As the global population ages, so does the demand for biologically-inspired systems that improve the quality of later life. VanEck’s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
-
NAV$21.49
as of 08 May 2024 -
YTD RETURNS3.83%
as of 08 May 2024 -
Total Net Assets$6.2 million
as of 08 May 2024 -
Total Expense Ratio0.55%
-
Inception Date02 Dec 2022
-
SFDR ClassificationArticle 9
Overview
Fund Description
As the global population ages, so does the demand for biologically-inspired systems that improve the quality of later life. VanEck’s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
- Invest in companies at the forefront of improving quality of life for the world’s ageing population
- Gain diversified exposure to companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments
- Access companies earning at least half their revenues from bionic engineering-related industries
- Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco
Risk Factors: Equity market risk, industry or sector concentration risk, risk of investing in smaller companies, technological risk. Please refer to the
and the Prospectus for other important information before investing.
Underlying Index
MVIS® Global Bionic Healthcare ESG Index (MVBIONTR)
Fund Highlights
- Invest in companies at the forefront of improving quality of life for the world’s ageing population
- Gain diversified exposure to companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments
- Access companies earning at least half their revenues from bionic engineering-related industries
- Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco
Risk Factors: Equity market risk, industry or sector concentration risk, risk of investing in smaller companies, technological risk. Please refer to the
and the Prospectus for other important information before investing.
Underlying Index
MVIS® Global Bionic Healthcare ESG Index (MVBIONTR)
Performance
Holdings
Portfolio
Literature
Index
Index Description
The MVIS Global Bionic Healthcare ESG Index is a global index that tracks the performance of the largest and most liquid companies in medical/dental or vision-related implants, bioprinting, or prosthesis.
Index Key Points
Underlying Index
MVIS® Global Bionic Healthcare ESG Index (MVBIONTR)
The Index Composition:
The MVIS®Global Bionic Healthcare ESG Index (MVBIONTR) tracks the performance of the largest and most liquid companies in medical/dental or vision-related implants, bioprinting, or prosthesis. MVBION covers at least 90% of the investable universe.
Companies initially eligible for inclusion in Index:
- Companies involved in bionic healthcare industries. This includes companies with at least 50% (25% forcurrent components) of their revenues from the following sub-themes:
Medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue. The index does not include companies involved in implantable or wearable devices or materials used only for cosmetic purposes - Companies with at least 50% of their revenues from sectors defined above
- Market capitalization greater than $150 million
- Three-month average daily turnover greater than $1 million
- Minimum trading volume of 250,000 shares each month over last 6 months
- Company weightings are capped at 10%.
Index provider: